Benefits
Breaks down histamine from food in the gut
DAO is the body's main enzyme for degrading histamine in the digestive tract. Taken before a meal, supplemental DAO adds to gut DAO so that some of the histamine in histamine-rich foods is broken down before it is absorbed. It works only on histamine in the gut, not on histamine already circulating in the body.
Support for people sensitive to histamine-rich foods
Small studies in people who react to histamine-rich foods have reported fewer or milder symptoms when DAO is taken before meals. The evidence is limited and mixed: an independent provocation study could not reliably reproduce histamine-intolerance symptoms, and the condition remains difficult to diagnose and is not universally accepted.
Studied for histamine-related migraine
In a randomized double-blind trial of 100 people with episodic migraine who had low DAO activity, taking DAO before meals modestly shortened headache duration versus placebo. This tested a specific group with measured DAO deficiency, and migraine has many triggers, so it is not evidence that DAO prevents migraine in general.
Explored for hives, fibromyalgia, and sleep
Small placebo-controlled trials have tested DAO in chronic hives (urticaria), fibromyalgia, and insomnia linked to DAO-gene variants, with some reporting improvements. These are early, small, mostly single-group studies and do not establish DAO as a treatment for any of these conditions.
Mechanism of action
Oxidative breakdown of histamine
DAO (a copper-dependent amine oxidase, also called AOC1) removes the amino group from histamine, converting it to an inactive aldehyde. In the gut wall this is the first-line route for clearing histamine that comes from food, before it can enter the bloodstream.
Works in the gut, not the bloodstream
Swallowed DAO is itself a protein and is not absorbed intact in meaningful amounts; it acts on histamine within the digestive tract. This is why it is taken right before meals and why it does not lower histamine already circulating in the body or replace antihistamine medicines.
The DAO-deficiency rationale
People with low DAO activity, whether from genetics (AOC1 variants), gut damage, or DAO-blocking drugs and alcohol, are thought to clear dietary histamine poorly. Supplemental DAO is meant to compensate at mealtimes. Serum DAO activity is used in research to identify likely responders, though its value as a diagnostic test is debated.
Clinical trials
Randomized, double-blind, placebo-controlled trial of oral porcine DAO before meals in migraine patients with confirmed low DAO activity (Izquierdo-Casas J, Comas-Basté O, Latorre-Moratalla ML, et al. 2019, Clin Nutr 38(1):152-158, PMID 29475774).
100 adults with episodic migraine and low serum DAO activity; DAO or placebo before meals for one month.
The DAO group had a modest reduction in headache duration versus placebo (roughly a 1.4-hour shorter attack), without a significant change in attack frequency. Limited to migraine patients with measured DAO deficiency, and from a manufacturer-linked research group.
Randomized, double-blind, placebo-controlled study of DAO supplementation added to antihistamine therapy in chronic spontaneous urticaria (Yacoub MR, Ramirez GA, Berti A, et al. 2018, Int Arch Allergy Immunol 176(3-4):268-271, PMID 29698966).
Adults with chronic spontaneous urticaria and reduced DAO activity.
DAO supplementation improved urticaria symptom scores versus placebo in this small study. Small sample and short duration; DAO was an add-on to standard antihistamines, not a replacement.
Randomized, double-blind, placebo-controlled crossover histamine-provocation study in patients diagnosed with histamine intolerance (Komericki P, Klein G, Reider N, et al. 2011, Wien Klin Wochenschr 123(1-2):15-20, PMID 21165702).
Patients with suspected histamine intolerance undergoing oral histamine provocation with and without DAO.
Oral histamine challenge failed to reproduce patients' individual symptoms, which argues that single-symptom provocation is not a sound way to confirm histamine intolerance. On the global measure, total symptom scores were significantly lower with DAO than with placebo (p = 0.014). An important independent study: it undercuts the diagnostic construct while still showing a signal for the enzyme itself.